Report overview
This report contains market size and forecasts of Living Biological Drugs in Global, including the following market information:
Global Living Biological Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Living Biological Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Single Strain Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Living Biological Drugs include Ardeypharman, Miyarisan Pharmaceutical, Ferring Pharmaceuticals, Seres Therapeutics, Infant Bacterial Therapeutics, Osel, Takeda, AOBiome and Synlogic, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Living Biological Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Living Biological Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Living Biological Drugs Market Segment Percentages, by Type, 2022 (%)
Single Strain
Multi Strain
Co-Culture
Global Living Biological Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Living Biological Drugs Market Segment Percentages, by Application, 2022 (%)
Digestive System
Urinary System
Skin System
Global Living Biological Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Living Biological Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Living Biological Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Living Biological Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ardeypharman
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Infant Bacterial Therapeutics
Osel
Takeda
AOBiome
Synlogic
Finch Therapeutics
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Luina Bio
List Labs
MatriSys Bioscience
